Sheaff Brock Investment Advisors LLC Buys Shares of 12,030 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sheaff Brock Investment Advisors LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 12,030 shares of the medical equipment provider's stock, valued at approximately $5,910,000.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Creekmur Asset Management LLC raised its stake in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the second quarter valued at approximately $26,000. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after buying an additional 35 shares during the last quarter. LRI Investments LLC bought a new position in Intuitive Surgical in the 1st quarter worth $30,000. Finally, LGT Financial Advisors LLC grew its position in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded down $10.19 during trading on Friday, reaching $527.61. The stock had a trading volume of 1,447,836 shares, compared to its average volume of 1,461,285. The business's 50-day moving average price is $498.17 and its 200 day moving average price is $456.22. Intuitive Surgical, Inc. has a 52 week low of $295.02 and a 52 week high of $544.38. The stock has a market capitalization of $187.92 billion, a PE ratio of 85.96, a P/E/G ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,655,048.26. This trade represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jamie Samath sold 269 shares of the business's stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now directly owns 8,757 shares of the company's stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 91,178 shares of company stock valued at $45,897,071 in the last 90 days. 0.90% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent analyst reports. Mizuho increased their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Truist Financial upped their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a report on Monday, October 14th. BTIG Research set a $535.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Finally, Piper Sandler restated an "overweight" rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.